Progress in Medicinal Chemistry by Lawton

Progress in Medicinal Chemistry

byLawtonEditorWitty

Hardcover | June 19, 2012

not yet rated|write a review

Pricing and Purchase Info

$255.61 online 
$325.69
Earn 1278 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Progress in Medicinal Chemistryprovides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.

  • Progress in Medicinal Chemistryprovides a review of eclectic developments in medicinal chemistry

About The Author

Dr Geoff Lawton has extensive experience in new medicine discovery across many therapeutic areas in both large and small companies and is a co-inventor of a marketed drug (Cilazapril). He is a former Director of Chemistry at Roche UK, and Vice-president Chemistry and Preclinical Sciences within Roche Bioscience, Palo Alto, USA. He was ...
Azorean Cooking: From My Family Table to Yours
Azorean Cooking: From My Family Table to Yours

by Maria Lawton

$31.19$33.00

In stock online

Available in stores

Then We Take Berlin
Then We Take Berlin

by John Lawton

$16.87$21.95

In stock online

Available in stores

Friends And Traitors
Friends And Traitors

by John Lawton

$33.37$37.50

Pre-order online

Not yet available in stores

Shop this author

Details & Specs

Title:Progress in Medicinal ChemistryFormat:HardcoverDimensions:160 pages, 9 × 6 × 0.98 inPublished:June 19, 2012Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123964938

ISBN - 13:9780123964939

Look for similar items by category:

Customer Reviews of Progress in Medicinal Chemistry

Reviews

Extra Content

Table of Contents

  1. Small Molecule Bromodomain Inhibitors: Extending the Druggable Epigenome
  2. Chun-wa Chung

  3. TRPV1 Antagonists: Clinical Setbacks and Prospects for Future Development
  4. Michael E. Kort and Philip R. Kym

  5. Multivalent Dual Pharmacology Muscarinic Antagonist and ß2Agonist (MABA) Molecules for the Treatment of COPD
  6. Adam D. Hughes, Alexander McNamara and Tod Steinfeld

  7. Hematopoietic Prostaglandin D-Synthase Inhibitors Sukanthini Thurairatnam